Health Xtension Science (HXS)

A PREMIUM SWISS COMPANY

HXS

about Us

Health Xtension Science (HXS) is a Swiss company dedicated to scientific anti-ageing evolutions and to improve health, well-being and beauty.

 

It is a unique brand providing premium cosmetics and food supplements with patented peptides, targeting both the inside and the outside of the human body for women and men.

 

Our goals are to slow, stop and reverse ageing-related signs, bringing women and men closer to their health and beauty aspirations.

HXS innovation is the unique combination of peptides with active substances and premium natural ingredients.

 

We are committed to produce exceptional products with the most efficient and qualitative natural and synthetic ingredients available amongst the best laboratories and professionals.

 

HXS aims to reduce the biological ageing for women and men and generate the highest level of  health and skin rejuvenation.

The most refined and advanced products available in cosmetics and biomolecular science today.

HXS products are based on peptides developed by Professor Vladimir Khavinson and his team, a world-leading specialist in Biomolecular Science with more than 40 years of experience and over 1000 scientific publications.

All products are developed by our team of Swiss and international specialists, and produced entirely in Switzerland under the most rigorous quality standards.

 

Switzerland is the world's leading country for the development, production and application of peptides.

Based in Switzerland, Health Xtension Science is the result of a collaboration between scientists and health experts with a vision to develop the next generation of anti-ageing solutions.

HXS philosophy

"What happens within our body always shows on the outside." Maintaining our internal organs in good health will reflect our external appearance in an immediate long lasting manner.

Scientific advisory board

The Scientific Advisory Board is constituted to have a breadth of expertise in the field of innovative solutions for preventing the age-related pathologies and promoting excellence in health information and products. The Scientific Advisory Board was formed to ensure that the messages and basis of HXS are evidence-based and scientifically sound.

 

The Board includes scholars who have made significant contributions to the research and science of metabolic, regenerative and anti-ageing medicine.

Our Team

  • Suzanne Bachmann, CEO and Founder of Health Xtension Science
  • Pr. Vladimir Khavinson
  • Dr Michel Sickenberg, MD
  • Olga Mikhailova, Ph.D.
  • Professor Galina A. Ryzhak, M.D., Ph.D
  • Suzanne Bachmann, CEO and Founder of Health Xtension Science

    “What happens within our body always shows on the outside. This is becoming generally accepted, especially for those who have experienced signs of ageing in their body and skin. HXS products are made to slow, stop and reverse ageing-related signs, helping women and men to improve or maintain peak quality of life with high quality cosmetics and food supplements.”

  • Pr. Vladimir Khavinson

    Prof. Khavinson has been a world-renowned scientist in the field of biogerontology, especially in the development of peptide to counter and bioregulate the ageing process for several decades. His numerous publications have made of him a well-recognized and unique specialist of peptide bioregulation. He is the author of 194 Russian and International patents.

     

    Since 40 years, Prof. Khavinson has been engaged in studying the role of peptides in the regulation of ageing mechanisms.

     

    He designed preclinical and clinical studies to test new peptide geroprotectors with success. Prof. Khavinson founded the Institute of Bioregulation and Gerontology in St Petersburg, an internationally recognized center by the United Nations and the International Association of Gerontology and Geriatrics. Prof. Khavinson is the author of over 700 scientific publications, however, the major achievements are summarized in his books “Peptides and Ageing” (NEL, 2002) and “Gerontological aspects of genome peptide regulation” (Karger AG, 2005).

  • Dr Michel Sickenberg, MD

    Dr Sickenberg is an ophthalmologist and surgeon, specialised in the treatment of low vision. Within his private practice in Lausanne Switzerland, he has been conducting research on peptide bioregulation of degenerative conditions with successful results in the improvement of the vision. He has been one of the pioneers in prescribing Avastin to treat age-related macular degeneration. He is also concerned about preventing age-related eye condtions and supports peptide supplements as an enhancer of eye health.

  • Olga Mikhailova, Ph.D.

    Mikhailova Olga, Ph.D. in Gerontology is a Deputy Director of the Saint Petersburg Institute of Bioregulation and Gerontology, Academic Secretary of the Gerontological Society of the Russian Academy of Sciences, Member of the Expert Committee at the Main Specialist in Gerontology and Geriatrics of the Government of Saint Petersburg. Since 2009 she is a Council Member of the International Association of Gerontology and Geriatrics (from Russia) and a Member of the Council of the INIA Satellite Centre for Eastern Europe in St. Petersburg. For the term of 2015-2017 she is approved by His Excellency Mr. Ban Ki-Moon, Secretary General of the United Nations, to serve on the Board of the International Institute on Ageing, United Nations – Malta. She is the author of about 90 publications on gerontology.

  • Professor Galina A. Ryzhak, M.D., Ph.D

    Deputy Director for Research & New Technologies and Head of the Laboratory of Age-related Clinical Pathology of the Saint Petersburg Institute of Bioregulation and Gerontology, Scientific Secretary of the Editorial Board of the Journal “Advances in Gerontology”, Deputy Chair of the Dissertation Council on Gerontology, Council Member of the International Association of Gerontology and Geriatrics (from Russia), author of over 400 research publication, 62 patents on biotechnology and pharmacology.